Mycoplasma Diagnostics Market

Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
Mycoplasma Diagnostics Market contains market size and forecasts of Mycoplasma Diagnostics in Global, including the following market information:
Global Mycoplasma Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Mycoplasma Diagnostics market was valued at 679.7 million in 2021 and is projected to reach US$ 1005.4 million by 2028, at a CAGR of 5.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Kits & Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mycoplasma Diagnostics include Agilent Technologies, Thermo Fisher Scientific, PromoCell, Charles River Laboratories International, Merck KGaA, Lonza Group, Takara Bio (Takara Holding Company.), Savyon Diagnostics and Tecan Trading (Tecan Group), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mycoplasma Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mycoplasma Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mycoplasma Diagnostics Market Segment Percentages, by Type, 2021 (%)
Kits & Reagents
Instruments
Software & Services
Global Mycoplasma Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Mycoplasma Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Laboratories
Clinics
Others
Global Mycoplasma Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Mycoplasma Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mycoplasma Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Mycoplasma Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche